Ftse Mib
33.427,72
-0,20%
DAX
19.405,20
0,51%
S&P 500
5.987,37
0,30%
NASDAQ
19.054,84
0,27%
Bitcoin
94.631,20
1,66%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Endonovo Therapeutics Inc (PK) (ENDV) Endonovo Therapeutics Inc (PK) (ENDV) Notizie

ENDV

Endonovo Therapeutics (PK) (ENDV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ENDV
DataOraFonteTitoloSimboloCompagnia
19/09/202421:00Edgar (US Regulatory)Form SEC STAFF ACTION - SEC Staff Action: ORDERUSOTC:ENDVEndonovo Therapeutics Inc (PK)
02/02/202423:23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
03/01/202423:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
29/12/202321:20Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
15/11/202318:21Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ENDVEndonovo Therapeutics Inc (PK)
25/08/202313:04Edgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
21/08/202323:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
14/06/202320:27Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/05/202312:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
17/04/202322:39Edgar (US Regulatory)Annual Report (10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
31/03/202321:55Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
29/03/202313:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
22/08/202215:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/07/202017:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ENDVEndonovo Therapeutics Inc (PK)
10/07/202022:32Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
07/07/202019:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ENDVEndonovo Therapeutics Inc (PK)
23/06/202022:02Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ENDVEndonovo Therapeutics Inc (PK)
09/06/202012:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ENDVEndonovo Therapeutics Inc (PK)
02/06/202013:59Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)USOTC:ENDVEndonovo Therapeutics Inc (PK)
02/06/202012:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ENDVEndonovo Therapeutics Inc (PK)
29/05/202023:32Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:ENDVEndonovo Therapeutics Inc (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ENDV

La tua Cronologia

BIT
UCG
Unicredit
BIT
BAMI
Banco BPM
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
SPM
Saipem
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
RACE
Ferrari NV
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network